Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to an internationally approved guideline and followed Good Laboratory Practices.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
not specified
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Reaction products of fatty acids, C14-C18 (branched and linear) and C18 (unsaturated) with tetraethylenepentamine (linear, branched, cyclic)
EC Number:
701-204-9
Cas Number:
68784-17-8
IUPAC Name:
Reaction products of fatty acids, C14-C18 (branched and linear) and C18 (unsaturated) with tetraethylenepentamine (linear, branched, cyclic)
Test material form:
liquid: viscous

Test animals

Species:
rabbit
Strain:
New Zealand White
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: L.I.T. Rabbitry, Whitehall, Montana
- Age at study initiation: The males/females were 15-17 weeks of age at the time of dosing.
- Weight at study initiation: The males weighed 2.95-3.48 kilograms, and the females weighed 2.99-3.40 kilograms at the time of dosing.
- Housing: The animals were housed individually in wire-bottom cages in an air-conditioned room.
- Diet (e.g. ad libitum): The animals were fed a daily ration of Purina Laboratory Rabbit Chow HF #5326.
- Water (e.g. ad libitum): Free access to water.
- Acclimation period: conditioning period of 51 days prior to dosing in the laboratory.

ENVIRONMENTAL CONDITIONS
- Temperature (°F): 70°F
- Humidity (%): 61.0-95.6%
- Photoperiod (hrs dark / hrs light): The photoperiod was a 12-hour light/dark cycle: lights on at 0630 and off at 1830.

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
The fur on the trunks of five animals of each sex was clipped on the day prior to dosing. Two grams per kilogram of body weight of the test material were applied to the trunk of each animal. The material was held in contact with the animal's skin by a plastic sheet wrapped around the animal's trunk, and paper towels were wrapped over the plastic sheet to prevent tearing. Collars were placed on the animals to prevent oral ingestion of the test material. The mean weights (+S.D.) of test material administered were 6.52 (0.43) g for males and 6.62 (0.16) g for females. FIve clipped animals of each sex, treated with 5.0 ml/kg of physiological saline, were wrapped as described above and served as the controls. The animals were dosed and wrapped approximately 4 - 5 hours after the onset of the light cycle.
After a 24-hour exposure period, the wrappings were removed from the animals. The remaining test material had become hardened and was unable to be removed with mineral oil, ethanol or acetone. The test material had adhered flaked away from the animals between Days 7 and 14. Collars remained on treated animals from Day 0 to Day 6 to prevent oral ingestion of residual test material and on controls for the same length of time.
Duration of exposure:
24 hours.
Doses:
2 g/kg bw of test material.
No. of animals per sex per dose:
5 per sex per dose
Control animals:
yes
Details on study design:
- Duration of observation period following administration: The animals were observed frequently for any physiological or behavioral abnormalities on the day of dosing and at least once each weekday morning and late afternoon for 13 days after treatment; on weekends, they were observed once daily. On Day 14, the animals were observed once prior to sacrifice.

The skin at the application site was scored for irritation at 1, 7, and 14 days after treatment using the modified scoring system of Draize et al.

- Frequency of observations and weighing: The animals were weighed immediately prior to dosing and at 2, 7, and 14 days after treatment. The mean body weights of the treated animals were compared to those of the respective controls using Student's t-test.

- Necropsy of survivors performed: yes, all survivors killed following the 14-day observation period were examined for gross pathological changes. The following organs and tissues were examined: skin, spleen, pancreas, stomach, small and large intestine, liver, adrenals, kidneys, gonads, uterus or seminal vesicles, bladder, heart, thymus, salivary glands, lungs, trachea, thyroid, and fat. Sections of skin from each animal and any abnormal tissues were preserved in 10% (v/v) neutral buffered formalin and submitted for histopathological examination.

- Other examinations performed: Tissues were submitted to Histopathology Reference Laboratory, Oakland, California, for tissue processing and preparation of routine five-micron H&E stained sections. Tissue sections were evaluated for microscopic abnormalities at Chevron Environmental Health Center, Inc.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality.
Clinical signs:
other: Signs of toxicity observed during the study included reduced food consumption in 4 treated animals of each sex from Day 1 to Day 7. Reddened nictitating membranes with yellow ocular discharge was observed in 2 females in the treated group. All treated a
Gross pathology:
Dry and flaky skin was observed in the application site of in all treated animals and slight erythema with no edema was present in three treated animals of each sex. A treated female was also observed to have a pin-point eschar in the application site. Patches of slight erythema with no edema was observed in the application site of a male and a pin-point eschar was observed in the application site of a female in the control group. Four females and one male in the control group were observed to have reddened skin in the taped region where eschars had sloughed. Another male in the control group was observed to have an abcess in the taped region.

A thymus with red-brown areas was observed in one female in the control group.

Microscopic compound related lesions in the skin consisted of trace to mild subchronic inflammation and hyperkeratosis; mild acanthosis and mild epidermal cursting were also observed. Similar lesions in the control group were much more focal or multifocal rather than diffuse in distribution pattern and did not occur in every rabbit.

Mild thymic congestion was an incidental observation occuring in a female in the control group.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The test article, when administered neat dermally to 5 male and 5 female New Zealand white rabbits had an acute dermal LD50 of greater than 2 g/kg.
Executive summary:

Five adult rabbits of each sex were treated with a single dermal application of 2.00 g/kg of test material. No mortality was observed. Signs of toxicity observed during the study were reduced food consumption in both treated sexes and reddened nictitating membranes and yellow ocular discharge in the treated females. The skin in the application site had become thickened and cracked with severe erythema and eschars between the cracks by day 7. Dry and flaky skin, pin-point eschars and slight erythema with no edema were observed at the application site of animals through sacrifice on day 14. Microscopic compound-related lesions in the skin consisted of trace to mild hyperkeratosis, epidermal crusting, dermal inflammation and acanthosis. There were no other treatment-related pathological changes.